Top of this page
Skip navigation, go straight to the content
UCB - Inspired by patients. Driven by science.
Menu
Our Company
About Us
Management
History
Location
Our Products
Products
Our Science
Our Science
Pipeline
Our Clinical Studies
UCB Worldwide
Search
Newsroom
Press releases
Contact
Careers
Applying to UCB
이메일문의
Home
Our Company
About Us
Management
History
Location
Our Products
Products
Our Science
Our Science
Pipeline
Our Clinical Studies
Newsroom
Press releases
Contact
Careers
Applying to UCB
검색
Language
×
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
Казахстан – ағылшын тілі
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zeeland – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – Inglês
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Français
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
Go To Global Site
한국 UCB 에 오신 것을 환영합니다
u
Facebook
Twitter
YouTube
LinkedIn
Scroll down to discover UCB
Mobile Menu
검색
UCB - Inspired by patients. Driven by science.
Press releases
Contact
ucbkorea.co.kr (NEW)
•
Newsroom
•
Press releases
Newsroom
기사보기
"20년 넘게 뇌전증 치료제 개발 주력...
한국서도 한 해 9만명 혜택"
기사보기
"한국UCB제약, 지속형 혈우병치료제
'엘록테이트' , '알프로릭스' 시판허가"
기사보기
"한국UCB제약 본사 이전식 개최로
새로운 출발 다짐"
